Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
  2. Yang, Yongping; Kong, Wing-Pui; Liu, Cuiping; Ruckwardt, Tracy J; Tsybovsky,Yaroslav; Wang, Lingshu; Wang, Shuishu; Biner, Daniel W; Chen, Man; Liu, Tracy; Merriam, Jonah; Olia, Adam S; Ou, Li; Qiu, Qi; Shi, Wei; Stephens,Tyler; Yang, Eun Sung; Zhang, Baoshan; Zhang, Yi; Zhou, Qiong; Rawi, Reda; Koup, Richard A; Mascola, John R; Kwong, Peter D
  3. Vaccines. 2023, Aug 31; 11(9):
  1. 2.   Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection
  2. Munson, Paul; Liu, Yi; Bratt, Debra; Fuller, James T; Hu, Xintao; Pavlakis, George; Felber, Barbara; Mullins, James I; Fuller, Deborah Heydenburg
  3. Human vaccines & immunotherapeutics. 2018, Apr 12; 14(7): 1820-1831.
  1. 3.   HIV Env conserved element DNA vaccine alters immunodominance in macaques
  2. Hu, Xintao; Valentin, Antonio; Rosati, Margherita; Manocheewa, Siriphan; Alicea, Candido; Chowdhury, Bhabadeb; Bear, Jenifer; Broderick, Kate E.; Sardesai, Niranjan Y.; Le Gall, John; Mullins, James I.; Pavlakis, George; Felber, Barbara
  3. Human Vaccines & Immunotherapeutics. 2017, Dec 2; 13(12): 2859-2871.
  1. 4.   Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques
  2. Kulkarni, V.; Jalah, R.; Ganneru, B.; Bergamaschi, C.; Alicea, C.; von Gegerfelt, A.; Patel, V.; Zhang, G. M.; Chowdhury, B.; Broderick, K. E.; Sardesai, N. Y.; Valentin, A.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2011, Sep; 29(39): 6742-6754.
  1. 5.   Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization
  2. Patel, V.; Valentin, A.; Kulkarni, V.; Rosati, M.; Bergamaschi, C.; Jalah, R.; Alicea, C.; Minang, J. T.; Trivett, M. T.; Ohlen, C.; Zhao, J.; Robert-Guroff, M.; Khan, A. S.; Draghia-Akli, R.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2010, Jul; 28(30): 4827-4836.
  1. 6.   FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
  2. Klinman, D. M.; Klaschik, S.; Tross, D.; Shirota, H.; Steinhagen, F.
  3. Vaccine. 2010, Apr; 28(16): 2801-2805.
  1. 7.   Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
  2. Valentin, A.; von Gegerfelt, A.; Rosati, M.; Miteloudis, G.; Alicea, C.; Bergamaschi, C.; Jalah, R.; Patel, V.; Khan, A. S.; Draghia-Akli, R.; Pavlakis, G. N.; Felber, B. K.
  3. Vaccine. 2010, Feb; 28(8): 1962-1974.
  1. 8.   Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys
  2. Wang, H. B.; Kondo, A.; Yoshida, A.; Yoshizaki, S.; Abe, S.; Bao, L. L.; Mizuki, N.; Ichino, M.; Klinman, D.; Okuda, K.; Shimada, M.
  3. Gene Therapy. 2010, Jan; 17(1): 4-13.
  1. 9.   DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge
  2. Rosati, M.; Bergamaschi, C.; Valentin, A.; Kulkarni, V.; Jalah, R.; Alicea, C.; Patel, V.; von Gegerfelt, A. S.; Montefiori, D. C.; Venzon, D. J.; Khan, A. S.; Draghia-Akli, R.; Van Rompay, K.; Felber, B. K.; Pavlakis, G. N.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(37): 15831-15836.
  1. 10.   Contribution of IRF-3 mediated IFN beta production to DNA vaccine dependent cellular immune responses
  2. Shirota, H.; Petrenko, L.; Hattori, T.; Klinman, D. M.
  3. Vaccine. 2009 27(15): 2144-2149.
  1. 11.   Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239
  2. Vagenas, P.; Williams, V. G.; Piatak, M.; Bess, J. W.; Lifson, J. D.; Blanchard, J. L.; Gettie, A.; Robbiani, M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 433-442.
  1. 12.   Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA+IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques
  2. Halwani, R.; Boyer, J. D.; Yassine-Diab, B.; Haddad, E. K.; Robinson, T. M.; Kumar, S.; Parkinson, R.; Wu, L.; Sidbu, M. K.; Phillipson-Weiner, R.; Pavlakis, G. N.; Felber, B. K.; Lewis, M. G.; Shen, A.; Siliciano, R. F.; Weiner, D. B.; Sekaly, R. P.
  3. Journal of Immunology. 2008 180(12): 7969-7979.
  1. 13.   Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses
  2. Robinson, T. M.; Sidhui, M. K.; Pavlakis, G. N.; Felber, B. K.; Silvera, P.; Lewis, M. G.; Eldridge, J.; Weiner, D. B.; Boyer, J. D.
  3. Journal of Medical Primatology. 2007, Aug; 36(4-5): 276-284.
  1. 15.   Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro
  2. Stone, G. W.; Barzee, S.; Snarsky, V.; Spina, C. A.; Lifson, J. D.; Pillai, V. K. B.; Amara, R. R.; Villinger, F.; Kornbluth, R. S.
  3. Clinical and Vaccine Immunology. 2006, Nov; 13(11): 1223-1230.
  1. 16.   Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization
  2. Herrmann, J. E.; Wang, S. X.; Zhang, C. Y.; Panchal, R. G.; Bavari, S.; Lyons, C. R.; Lovchik, J. A.; Golding, B.; Shiloach, J.; Lu, S.
  3. Vaccine. 2006, Jul; 24(31-32): 5872-5880.
  1. 17.   Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239
  2. Boyer, J. D.; Maciag, P. C.; Parkinson, R.; Wu, L.; Lewis, M. G.; Weiner, D. B.; Paterson, Y.
  3. Vaccine. 2006, May; 24(21): 4498-4502.
  1. 18.   Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag
  2. Zhao, J.; Voltan, R.; Peng, B.; vis-Warren, A.; Kalyanaraman, V. S.; Alvord, W. G.; Aldrich, K.; Bernasconi, D.; Butto, S.; Cafaro, A.; Ensoli, B.; Robert-Guroff, M.
  3. Virology. 2005, NOV 10; 342(1): 1-12.
  1. 19.   DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
  2. Rosati, M.; von Gegerfelt, A.; Roth, P.; Alicea, C.; Valentin, A.; Robert-Guroff, M.; Venzon, D.; Montefiori, D. C.; Markham, P.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 2005, JUL; 79(13): 8480-8492.
  1. 20.   An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS
  2. Wang, S. W.; Bertley, F. M. N.; Kozlowski, P. A.; Herrmann, L.; Manson, K.; Mazzara, G.; Piatak, M.; Johnson, R. P.; Carville, A.; Mansfield, K.; Aldovini, A.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 846-859.
  1. 21.   Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles
  2. Mossman, S. P.; Pierce, C. C.; Watson, A. J.; Robertson, M. N.; Montefiori, D. C.; Kuller, L.; Richardson, B. A.; Bradshaw, J. D.; Munn, R. J.; Hu, S. L.; Greenberg, P. D.; Benveniste, R. E.; Haigwood, N. L.
  3. Aids Research and Human Retroviruses. 2004 20(4): 425-434.
  1. 22.   A simian replication-defective vaccine to HIV-1 gag
  2. Fitzgerald, J. C.; Gao, G. P.; Reyes-Sandoval, A.; Pavlakis, G. N.; Xiang, Z. Q.; Wlazlo, A. P.; Giles-Davis, W.; Wilson, J. M.; Ertl, H. C. J.
  3. Journal of Immunology. 2003 170(3): 1416-1422.
  1. 24.   Next generation DNA vaccines for HIV-1
  2. Boyer, J. D.; Chattergoon, M.; Muthumani, K.; Kudchodkar, S.; Kim, J.; Bagarazzi, M.; Pavlakis, G.; Sekaly, R.; Weiner, D. B.
  3. Journal of Liposome Research. 2002 12(1-2): 137-142.
  1. 25.   Issues for improving multiplasmid DNA vaccines for HIV-1
  2. Muthumani, K.; Kudchodkar, S.; Zhang, D. H.; Bagarazzi, M. L.; Kim, J. J.; Boyer, J. D.; Ayyavoo, V.; Pavlakis, G. N.; Weiner, D. B.
  3. Vaccine. 2002 20(15, Special Issue): 1999-2003.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel